Chondromyxoid fibroma

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:404507D16.9
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Chondromyxoid fibroma (CMF) is a rare, benign (non-cancerous) bone tumor. It is one of the least common bone tumors, making up less than 1% of all bone tumors. Despite being benign, it can cause significant discomfort and problems depending on where it grows. The tumor is made up of a mix of cartilage-like tissue and a jelly-like substance called myxoid tissue, along with fibrous tissue. Chondromyxoid fibroma most often develops in the long bones of the legs, particularly the tibia (shinbone) and the bones around the knee. However, it can also appear in the pelvis, foot bones, and other locations. The most common symptom is a dull, aching pain in the affected area that may gradually worsen over time. Some people notice swelling or a firm lump near the tumor. In some cases, the tumor weakens the bone enough to cause a fracture with minimal injury. This tumor is most frequently diagnosed in teenagers and young adults, typically between the ages of 10 and 30. Males are slightly more often affected than females. The main treatment is surgery to remove the tumor. While chondromyxoid fibroma does not spread to other parts of the body, it can come back after surgery in some cases, so follow-up monitoring is important. The overall outlook is very good, as this is a benign condition with excellent survival rates.

Key symptoms:

Dull or aching bone painSwelling near the affected boneA firm lump or mass that can be feltPain that worsens over timeLimited movement in a nearby jointTenderness when pressing on the areaBone fracture from minor injury (pathologic fracture)Stiffness in the affected limbLimping or difficulty walking if the leg is affectedMuscle weakness near the tumor

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Juvenile

Begins in the teen years

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Chondromyxoid fibroma.

View clinical trials →

No actively recruiting trials found for Chondromyxoid fibroma at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Chondromyxoid fibroma community →

No specialists are currently listed for Chondromyxoid fibroma.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Chondromyxoid fibroma.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Chondromyxoid fibromaForum →

No community posts yet. Be the first to share your experience with Chondromyxoid fibroma.

Start the conversation →

Latest news about Chondromyxoid fibroma

No recent news articles for Chondromyxoid fibroma.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What is the exact location and size of the tumor, and how does that affect my treatment options?,What type of surgery do you recommend — curettage or wider excision — and why?,What is the expected recurrence rate with the recommended surgical approach?,How long will recovery take, and will I need physical therapy afterward?,How often will I need follow-up imaging to check for recurrence?,Are there any activity restrictions I should follow before or after surgery?,Could this tumor be anything other than a chondromyxoid fibroma, and how will you confirm the diagnosis?

Common questions about Chondromyxoid fibroma

What is Chondromyxoid fibroma?

Chondromyxoid fibroma (CMF) is a rare, benign (non-cancerous) bone tumor. It is one of the least common bone tumors, making up less than 1% of all bone tumors. Despite being benign, it can cause significant discomfort and problems depending on where it grows. The tumor is made up of a mix of cartilage-like tissue and a jelly-like substance called myxoid tissue, along with fibrous tissue. Chondromyxoid fibroma most often develops in the long bones of the legs, particularly the tibia (shinbone) and the bones around the knee. However, it can also appear in the pelvis, foot bones, and other locat

How is Chondromyxoid fibroma inherited?

Chondromyxoid fibroma follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Chondromyxoid fibroma typically begin?

Typical onset of Chondromyxoid fibroma is juvenile. Age of onset can vary across affected individuals.